Predictors of depressive symptomatology of geriatric patients with lung cancer—a longitudinal analysis

Kurtz, Margot E.; Kurtz, J. C.; Stommel, Manfred; Given, Charles W.; Given, Barbara

doi:10.1002/pon.545

Cited by 93 publications

(78 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Findings regarding the effects that demographic characteristics of age and gender have on symptoms are contradictory; some studies have found older age and being female to be associated with higher symptom prevalence (Walsh et al, 2000), while others have not (Kurtz et al, 2002). Biomedical characteristics of the individual -such as comorbid conditions, and stage and site of the cancer-have clearly been shown to affect symptoms (Yancik et al, 2001a;Zabora et al, 2001).…”

Section: Theoretical Framework: Cognitive Behavioral Interventionsmentioning

confidence: 98%

“…Depressive symptoms have been associated with the sensory dimension of a symptom or symptom severity (Kurtz et al, 2002). Although the association of depression on symptom limitation has yet to be explored, one can assume that depression may also impact a participant's report of the reactive dimension of a symptom or symptom severity.…”

Section: Theoretical Framework: Cognitive Behavioral Interventionsmentioning

confidence: 99%

See 1 more Smart Citation

Reducing symptom limitations: A cognitive behavioral intervention randomized trial

Doorenbos

Given

et al. 2005

Psycho-Oncology

View full text Add to dashboard Cite

SUMMARYUntil now, little research has been conducted examining the reactive dimension, or the degree to which a symptom limits an individual's life, in a multiplicity of symptoms. This research examines how problem-solving therapy organizes an intervention to decrease symptom limitations. The purpose was threefold: to determine if a cognitive behavioral intervention decreases the impact of symptom limitations among individuals newly diagnosed with cancer, who are receiving chemotherapy; to determine, after adjusting for covariates, how symptom limitations change over time; and to describe which symptoms are most limiting. This randomized control trial was conducted in two comprehensive and four community cancer centers. Two hundred thirty-seven individuals, aged 31-87, newly diagnosed with solid tumor cancers, participated. The experimental group (118 individuals) received a 10-contact, 18-week cognitive behavioral intervention focused on cancerand chemotherapy-related symptoms. The control group (119 individuals) received conventional care. Interviews occurred at baseline, 10, 20, and 32 weeks. Data analysis used a two-level hierarchical linear model. Participants receiving the cognitive behavioral intervention had lower scores of symptom limitation than did participants in the control group. At the onset of the study, younger patients reported more symptom limitations than their older counterparts; however, this was reversed by the end of the study. The cognitive behavioral intervention was key to decreasing symptom limitations. Findings also suggest that nursing interventions may be particularly helpful to younger individuals in managing cancer-related symptom limitations.

show abstract

Section: Theoretical Framework: Cognitive Behavioral Interventionsmentioning

confidence: 98%

Section: Theoretical Framework: Cognitive Behavioral Interventionsmentioning

confidence: 99%

Reducing symptom limitations: A cognitive behavioral intervention randomized trial

Doorenbos

Given

et al. 2005

Psycho-Oncology

View full text Add to dashboard Cite

show abstract

“…Distress has been defined as "a multifactorial, unpleasant experience of an emotional, psychological, social, or spiritual nature that interferes with the ability to cope with cancer, its physical symptoms, and its treatment" [1,2]. In the oncology context, distress is multifactorial, as numerous areas in a patient's life contribute to his or her experience of distress, including physical symptoms, disease severity, treatment [3,4]; physical activity level / performance status [5][6][7]; social support (for a review see [8]); and psychological factors such as optimism [9,10], coping style [11,12], and pre-morbid or current depression [13].…”

Section: Introductionmentioning

confidence: 99%

Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distress

et al. 2007

View full text Add to dashboard Cite

SummaryScreening for distress in cancer patients is recommended by the National Comprehensive Cancer Network, and a Distress Thermometer has previously been developed and empirically-validated for this purpose. The present study sought to determine the rates and predictors of distress in a sample of patients being seen in a multidisciplinary lung cancer clinic. Consecutive patients (N = 333) were recruited from an outpatient multidisciplinary lung cancer clinic to complete the Distress Thermometer, an associated Problem Symptom List, and two questions about interest in receiving help for symptoms. Over half (61.6%) of patients reported distress at a clinically significant level, and 22.5% of patients indicated interest in receiving help with their distress and/or symptoms. Problems in the areas of family relationships, emotional functioning, lack of information about diagnosis/treatment, physical functioning, and cognitive functioning were associated with higher reports of distress. Specific symptoms of depression, anxiety, pain and fatigue were most predictive of distress. Younger age was also associated with higher levels of distress. Distress was not associated with other clinical variables, including stage of illness or medical treatment approach. Similar results were obtained when individuals who had not yet received a definitive diagnosis of lung cancer (n = 134) were excluded from analyses; however, family problems and anxiety were no longer predictive of distress. Screening for distress in a multidisciplinary lung cancer clinic is feasible and a significant number of patients can be expected to meet clinical criteria for distress. Results also highlight younger age and specific physical and psychosocial symptoms as predictive of clinically-significant distress. Identification of the presence and predictors of distress are the first steps toward appropriate referral and treatment of symptoms and problems that contribute to cancer patients' distress.

show abstract

“…Previous research has also found a relationship between depression and symptom severity (13). Additionally, certain sites of cancer are known to have a shorter life expectancy than others, for example, lung cancer compared to breast cancer (1).…”

Section: Introductionmentioning

confidence: 99%

Symptom Experience in the Last Year of Life Among Individuals with Cancer

Doorenbos

Given

et al. 2006

Journal of Pain and Symptom Management

View full text Add to dashboard Cite

Individuals with cancer often experience many symptoms that impair their quality of life at end of life. This study examines symptom experience at end of life among individuals with cancer, and determines if symptom experience changes with proximity to death, or differs by depressive symptomatology, sex, site of cancer, or age. A secondary analysis of data from three prospective, descriptive, longitudinal studies (n = 174) was performed, using a three-level hierarchical linear model. Fatigue, weakness, pain, shortness of breath, and cough were the five most prevalent symptoms in the last year of life. The symptom experience in the last year of life was significantly associated with site of cancer, depressive symptomatology, dependencies in activities of daily living, and independent activities of daily living at the start of the study. These findings shed light on the symptom experience in the last year of life for individuals with cancer. With greater understanding of the symptom experience, intervention strategies can be targeted to achieve the desired outcome of increased quality of life at end of life.

show abstract

Predictors of depressive symptomatology of geriatric patients with lung cancer—a longitudinal analysis

Abstract: At a clinical level of patient care, these findings mandate early identification of psychosocial difficulties experienced, an individualized symptom management plan and the application of other interventions, such as information giving, reassurance and referral to other resources.

Cited by 93 publications

References 26 publications

Reducing symptom limitations: A cognitive behavioral intervention randomized trial

Reducing symptom limitations: A cognitive behavioral intervention randomized trial

Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distress

Symptom Experience in the Last Year of Life Among Individuals with Cancer

Contact Info

Product

Resources

About